Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q3 2019 · 10-Q
Revenue$21.49M$21.49M+28.9% vs Q3 2018 Net Income$1.14M$1.14MN/M vs Q3 2018 EPS Diluted$0.05$0.05N/M vs Q3 2018 Gross Profit$12,238,000+26.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,215,000+55.0% Free Cash Flowderived$4,098,000+158.4% Margins · derivedGross margin57.0%−1.1 pt vs Q3 2018
Operating margin7.7%+8.3 pt vs Q3 2018
Net margin5.3%+8.4 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end